600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd. [600062.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

600062.SS Stock Summary

Top 10 Correlated ETFs

600062.SS

Top 10 Correlated Stocks

600062.SS

In the News

600062.SS Financial details

Company Rating
-
Market Cap
20.18B
Income
1.33B
Revenue
10.22B
Book val./share
-
Cash/share
-
Dividend
0.29
Dividend %
1.62%
Employees
12.27K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
14.45
Forward P/E
-
PEG
-16.47
P/S
1.88
P/B
1.68
P/C
-
P/FCF
19.19
Quick Ratio
1.97
Current Ratio
2.54
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.04
EPS next Y
-
EPS next Q
-
EPS this Y
14.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.18%
Revenue last 5Y
1.47%
Revenue Q/Q
15.77%
EPS Q/Q
-
-
-
-
-
SMA20
-3.16%
SMA50
-4.06%
SMA100
-13.41%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
12%
ROC
0.12%
Gross Margin
55%
Oper. Margin
15%
Profit Margin
13%
Payout
48%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
14.8-22.22
52W High
-14.27%
52W Low
+34.71%
RSI
55.55
Rel Volume
0.97
Avg Volume
10.5M
Volume
10.15M
Perf Week
3.34%
Perf Month
-3.82%
Perf Quarter
-12.12%
Perf Half Y
-16.92%
-
-
-
-
Beta
0.118
-
-
Volatility
0.28%, 0.52%
Prev Close
0.27%
Price
18.86
Change
0.75%

600062.SS Financial Performance

600062.SS Dividend History

600062.SS Frequently Asked Questions

What is China Resources Double-Crane Pharmaceutical Co.,Ltd. stock symbol ?

China Resources Double-Crane Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 600062.SS

What is China Resources Double-Crane Pharmaceutical Co.,Ltd. stock quote today ?

China Resources Double-Crane Pharmaceutical Co.,Ltd. stock price is $18.86 today.

Is China Resources Double-Crane Pharmaceutical Co.,Ltd. stock public?

Yes, China Resources Double-Crane Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
TL0.DE
MSF.DE
ABEA.DE
BRH.DE
META
Top Correlated ETFs
KWEB
CWEB
HDV
PGJ
PHDG
Top Correlated Stocks
300357.SZ
688185.SS
600211.SS
300171.SZ
000623.SZ
Similar Market Cap
6282.TW
9927.TW
0EV1.L
AJINY
VNA.DE

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 10.5M
  • Market Capitalization 20.18B
  • Employee 12.27K
  • CEO Mr. Wenchao Lu
  • Headquarters Beijing,CN
  • IPO Date 1997-05-22
  • Website https://www.dcpc.com

China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China. The company offers soft bag, plastic and glass bottle, inner sealed polypropylene, and polypropylene blend bag infusion products; levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, sodium chloride injection products, etc.; and peritoneal dialysate, hemodialysis dialysate, etc. It also provides compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, edaravone, and other products to treat cardiovascular and cerebrovascular diseases. In addition, the company offers products for endocrinology; and pediatric compound amino acid injection, and other drugs to treat pediatrics. Further, it provides nutritional drugs, including vitamin E and C; and anti-infective drugs. The company is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. is a subsidiary of Beijing Pharmaceutical Group Co., Ltd.